| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42dcb8afd289e295b65f450020cbfdb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
| filingDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1118656d5154e103ceeea4412b9d305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8439296e8a9657951a04ad1ab996a06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54b00240c8e9d78a8d2e9d2a61fa0180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184fbda0566f4bdb29ce22ce9df404c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b67225e848c114556f906ee586b62a4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_351eccb6f3ef45b102af638579e80e5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_117eb04acd5eea98d61156dab821f735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f202c52f3f053ace2c69f7acfaac0191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608ed5a6668bee519765cada6e3f624b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ffa6660178947d1f885e513c6e1d22f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41de93b45ed027ad5ce32071adbdc784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b79131766411a257848ecc977541ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_408e95271330cd51c0d0c412b546bbb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc3a69f9815606a9ca62edecd218b13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73bfd125b86e9b8c08e9bb89509a0ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b54ffd029b1f0ec532391efd56036b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2dd32c658f8abc528b0866cc5455ffd |
| publicationDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2010253852-A1 |
| titleOfInvention |
Methods for treating cancer and non-neoplastic conditions |
| abstract |
Compounds that selectively inhibit pathological production of human vascular endothelial growth factor (VEGF) and compositions comprising such Compounds are described. Compounds that inhibit viral replication or the production of viral RNA or DNA or viral protein and compositions comprising such Compounds are described. Also described are methods of reducing VEGF using such Compounds and methods for treating cancer and non-neoplastic conditions involving the administration of such Compounds. Further described are methods of inhibiting viral replication or the production of viral RNA or DNA or viral protein using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments. |
| priorityDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |